Alovudine

Drug Profile

Alovudine

Alternative Names: CL 184824; FddThd; FLT; MIV-310

Latest Information Update: 28 Dec 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medivir AB
  • Class Antiretrovirals; Nucleosides; Small molecules
  • Mechanism of Action Nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 21 Dec 2007 Alovudine is no longer licensed to Presidio Pharmaceuticals worldwide
  • 21 Dec 2007 Aluvodine licensed to Beijing Mefuvir Medicinal Technology in Asia (excluding Japan)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top